U.S. Markets close in 2 hrs 53 mins

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.6500-0.3500 (-7.00%)
As of 01:00PM EST. Market open.

Nephros, Inc.

380 Lackawanna Place
South Orange, NJ 07079
United States
201 343 5202

IndustryMedical Instruments & Supplies
Full Time Employees27

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrew AstorCEO, CFO, Pres & Director309.01kN/A1957
Mr. Daron G. EvansChief Exec. Officer of Specialty Renal Products, Inc300.18kN/A1974
Ms. Joleen C. TurnerVP of Marketing & Bus. Devel.N/AN/AN/A
Mr. Shane SullivanVP of SalesN/AN/AN/A
Mr. Wesley S. LoboChief Commercial OfficerN/AN/A1977
Mr. Greg LucasPres of Aether Water SystemsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company operates through three segments: Water Filtration, Pathogen Detection, and Renal Products. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company develops and sells water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. Nephros, Inc. was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Corporate Governance

Nephros, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.